Compound ID | 3287
Synonym(s): taurolin
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Streptococcus faecalis, and Clostridium perfringens |
| Description: | Synthetic compound; formulates as taurolidine heparin sodium solution to additionally reduce thrombosis |
| Institute where first reported: | Cormedix |
| Year first mentioned: | 1977 |
| Highest development stage: | Approved by FDA in 2023 |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/29566 |
| Guide to Pharmacology: | taurolidine |
| Citations: |
|